无机材料学报

• 研究论文 • 上一篇    下一篇

多孔硅酸钙生物陶瓷体内非骨性环境的植入研究

许宋锋1, 胡蕴玉1, 林开利2, 王臻1, 王林1, 常江2, 白峰1, 倪似愚3   

  1. 1. 第四军医大学西京医院全军骨科研究所, 西安 710032; 2. 中国科学院上海硅酸盐研究所, 上海 200050; 3. 东华大学生物科学与技术研究所, 上海 201620
  • 收稿日期:2007-06-25 修回日期:2007-09-22 出版日期:2008-05-20 网络出版日期:2008-05-20

In Vivo Study of Porous Calcium Silicate Bioceramic in Extra-osseous Sites

XU Song-Feng1, HU Yun-Yu1, LIN Kai-Li2, WANG Zhen1, WANG Lin1, CHANG Jiang2, BAI Feng1, NI Si-Yu3   

  1. 1. Institute of Orthopedic Surgery, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China; 2. Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China; 3. Institute of Biological Sciences and Biotechnology, Donghua University, Shanghai 201620, China
  • Received:2007-06-25 Revised:2007-09-22 Published:2008-05-20 Online:2008-05-20

摘要: 采用泡沫浸渍法制备了多孔硅酸钙(CS)和β-磷酸三钙(β-TCP)生物陶瓷材料, 将其植入家兔皮下筋膜组织中以研究其非骨性环境下的生物学行为. CS, β-TCP分别植入1、2、4周后取材, 采用SPECT、Micro-CT、V-G染色、SEM、EDX等方法进行样品的观察分析. 研究表明, 多孔硅酸钙生物陶瓷植入后未见明显毒性反应、且表面沉积了一层类骨羟基磷灰石层, 说明材料具有良好的生物相容性和生物活性. 植入4周时SPECT扫描表明, CS和β-TCP的ROI值分别为53.95±15.14和9.81±3.64(p<0.01), 表明CS的血管化程度明显高于β-TCP. 植入4周时Micro-CT分析表明, CS和β-TCP的残余材料占总体积百分比分别为(16.41±1.96)%和(30.72±0.69)%(p<0.05), 组织学半定量分析也表明, CS的残余面积明显小于β-TCP(p<0.01), 说明CS的降解性明显优于β-TCP. 与β-磷酸三钙相比较, 多孔硅酸钙陶瓷材料在早期血管化、新生组织形成、材料降解性方面均具有明显优势. 研究结果显示, 多孔硅酸钙生物陶瓷有望用作硬组织修复和组织工程用支架材料.

关键词: 多孔硅酸钙, 生物陶瓷, 动物实验, 降解性, 血管化

Abstract: Porous calcium silicate (CS) and β-tricalcium phosphate (β-TCP) bioceramics were obtained by sintering polymeric sponges infiltrated with ceramic slurry. They were implanted in rabbit subcutaneous sites and the biological characteristics were investigated. After 1, 2 and 4 weeks implantation, specimens were harvested and analyzed by SPECT, Von Gieson staining, Micro-CT, SEM and EDX. There is no obvious toxic reaction in porous CS ceramics, showing the excellent biocompatibility of CS ceramics. In SPECT scanning, the ROI of CS and β-TCP is (53.95±15.14) and (9.81±3.64), respectively (p<0.01), showing higher vascularization for CS. In Micro-CT analysis, the percentage of residual material volume fraction of CS and β-TCP after 4 weeks implantation is 16.41%±1.96% and 30.72%±0.69% respectively (p<0.01). In semi-quantitative analysis of histological observation, the percentage of residual material in CS is obviously lower than that in β-TCP. These results show that the biodegradation of CS is higher than that of β-TCP. The deposition of the bone-like hydroxyapatite layer after 2 week implantation show good bioactivity of CS in vivo. In conclusion, compared with β-TCP, porous CS bioceramics have superiority in vascularization, ingrowth of new tissue and degradation in early stage. Therefore, porous CS bioceramics may be potential candidates as biocompatible, bioactive and biodegradable scaffolds for hard tissue repair and tissue engineering applications.

Key words: porous calcium silicate, bioceramics, animal experiment, degradability, vascularization

中图分类号: